meRfi®-GM
Akkermansia muciniphila
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
GeneBankAC: CP001071
A lower abundance of Akkermansia muciniphila has been associated with multiple diseases in both mouse models and in humans
A. muciniphila has proven efficacy to improve obesity, type 2 and type 1 diabetes mellitus, hepatic steatosis, [intestinal inflammation](brain://Eldiaq62UEOflHlBhwErSA/AkkermansiaMuciniphilaIntestinalInflammation…
References (Sources)
- Akkermansia glycaniphila sp. nov., an anaerobic mucin-degrading bacterium isolated from reticulated python faeces
- Akkermansia Muciniphila in the Human Gastrointestinal Tract: When, Where, and How?
- Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro
- Baseline human gut microbiota profile in healthy people and standard reporting template
- Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly
- Microbiome and Gut Dysbiosis
- The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract